Exploring Alternatives: What is Similar to Wegovy for Weight Loss?

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) transformed weight management when it entered the market, but it's far from the only option available for people seeking GLP-1 therapy. PlexusDx provides access to multiple compounded medications that work through similar biological pathways, each with distinct advantages depending on your individual metabolic profile and treatment goals.

How Semaglutide Compares to Other GLP-1 Medications

Semaglutide activates the glucagon-like peptide-1 receptor, which signals fullness to your brain and slows stomach emptying. This mechanism reduces appetite and calorie intake naturally. Clinical trials show semaglutide users lose approximately 15% of body weight over 68 weeks, making it an industry standard. However, newer compounds like tirzepatide activate two receptors (GLP-1 and GIP), which may produce stronger weight reduction in some patients.

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies. This pricing structure remains flat regardless of your dose—your dose may need to go up, but your price won't. Oral semaglutide tablets represent another alternative for patients who prefer not to inject, at $289/mo month-to-month, or from $249/mo on the 6-month plan. Both formulations deliver the same active ingredient through different delivery methods.

Tirzepatide: The Dual-Receptor Alternative to Semaglutide

Tirzepatide (brand name Zepbound) activates both GLP-1 and GIP receptors simultaneously, creating a dual-hormone mechanism that may surpass single-receptor activation. Recent studies demonstrate tirzepatide produces weight loss of 20-22% in some patients, outperforming semaglutide's typical 15% reduction. This superior efficacy comes from engaging an additional metabolic pathway that influences hunger, insulin sensitivity, and energy expenditure.

PlexusDx provides compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with oral tirzepatide tablets at $349/mo (or $279/mo on the 6-month plan). Both formulations come from licensed 503A compounding pharmacies and serve all 50 states without requiring insurance. For patients wanting to explore both compounds, PlexusDx's GLP-Squared dual-compound injection combines semaglutide and tirzepatide in one formulation, at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Understanding Your Genetic Response to GLP-1 Therapy

Not all patients respond identically to semaglutide or tirzepatide—genetic variation plays a significant role in treatment efficacy and side effect tolerance. PlexusDx's Precision Peptide Genetic Test identifies your unique peptide-pathway genetics by analyzing key variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This test maps 14 distinct metabolic pathways and provides 150+ genetic insights to guide medication selection.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Cost-Effective Access Without Insurance or Membership Fees

Traditional Wegovy through insurance requires high copays and extensive prior authorization delays. PlexusDx eliminates these barriers with transparent, flat monthly pricing and no membership requirements. Compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan while compounded tirzepatide is $289 monthly month-to-month—both significantly lower than brand-name alternatives. All medications come from licensed 503A compounding pharmacies regulated by state boards and the FDA.

Patients may use HSA or FSA funds to pay for PlexusDx medications and genetic testing, stretching healthcare dollars further. Service extends to all 50 states with direct-to-patient shipping and no insurance gatekeeping. This direct-access model democratizes access to GLP-1 therapy for people previously priced out of weight loss treatment.

Microdose Protocols for GLP-1 Sensitivity or Side Effects

Some patients experience nausea, constipation, or other gastrointestinal effects when starting standard GLP-1 doses. PlexusDx's Microdose GLP-1 Protocol delivers $129 monthly access to lower-dose formulations designed for patients with heightened medication sensitivity or those preferring gentler titration. This option maintains therapeutic benefit while minimizing tolerability concerns that sometimes lead to treatment discontinuation.

Microdose protocols allow your body to adapt gradually to GLP-1 activation, potentially reducing side effects while achieving steady weight loss. Many patients successfully transition from microdose formulations to standard doses after 4-8 weeks once tolerance develops. This flexible approach respects individual physiology and improves long-term adherence to weight loss therapy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is PlexusDx semaglutide the same as Wegovy?

PlexusDx offers compounded semaglutide from licensed 503A pharmacies containing the same active ingredient as Wegovy, but at lower cost ($189/month vs. brand-name pricing). Compounded medications are not FDA-approved but are legally regulated by state pharmacy boards and the FDA. Many patients find compounded semaglutide equally effective while reducing out-of-pocket expenses.

What clinical evidence supports tirzepatide over semaglutide?

SURMOUNT trials demonstrate tirzepatide produces 20-22% weight loss compared to semaglutide's 15% reduction. Tirzepatide's dual GLP-1/GIP activation engages additional metabolic pathways controlling hunger and glucose metabolism. For patients seeking maximum efficacy, tirzepatide represents a scientifically validated step forward in GLP-1 receptor agonist therapy.

Does PlexusDx require insurance or membership?

No—PlexusDx serves all 50 states without requiring insurance or charging membership fees. Medications are $189/mo month-to-month, or from $149/mo on the 6-month plan and are HSA/FSA eligible, giving patients direct access to compounded semaglutide and tirzepatide without prior authorization delays. Transparent flat pricing means your dose may increase without your monthly cost changing.

Are side effects from compounded semaglutide different than brand-name?

Compounded semaglutide contains identical active ingredient to Wegovy, so side effect profiles are similar—primarily nausea, constipation, and appetite suppression. PlexusDx's Microdose GLP-1 Protocol ($129/month) helps patients sensitive to standard doses by delivering lower initial concentrations. Most gastrointestinal effects resolve within 2-4 weeks as your body adapts.

How does the Precision Peptide Genetic Test personalize my medication choice?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.